Vaginal cuff brachytherapy practice in endometrial cancer patients: a report from the Turkish Oncology Group

被引:1
|
作者
Bolukbasi, Yasemin [1 ,2 ]
Onal, Cem [3 ]
Ozsaran, Zeynep [4 ]
Senyurek, Sukran [1 ]
Akdemir, Eyub Yasar [1 ]
Selek, Ugur [1 ]
Yildiz, Ferah [5 ]
机构
[1] Koc Univ, Fac Med, Dept Radiat Oncol, Davutpasa Caddesi 4, TR-34010 Istanbul, Turkey
[2] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[3] Baskent Univ, Fac Med, Dept Radiat Oncol, Adana Dr Turgut Noyan Res & Treatment Ctr, Adana, Turkey
[4] Ege Univ, Fac Med, Dept Radiat Oncol, Izmir, Turkey
[5] Hacettepe Univ Ankara, Fac Med, Dept Radiat Oncol, Ankara, Turkey
关键词
brachytherapy; vaginal cuff; experience; survey; DOSE-RATE BRACHYTHERAPY; AMERICAN BRACHYTHERAPY; PRACTICE PATTERNS; RISK; RADIOTHERAPY; ORGANS; DOSIMETRY; CARCINOMA; STENOSIS; TRENDS;
D O I
10.5114/jcb.2021.105282
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The American Brachytherapy Association is attempting to develop standards for delivering brachytherapy, although differences in practice have been reported in the literature. This study evaluated vaginal cuff brachytherapy (VBT) practice and quality of life-related recommendations among Turkish radiation oncologists. Material and methods: A nationwide web-based 17-item survey was distributed to the members of the Turkish Society for Radiation Oncology. These members received e-mail notifications, and a link was posted on the Turkish Society for Radiation Oncology internet site to solicit voluntary responses The survey addressed the simulation processes, target volume, prescribed dose, delivery schedules, and recommendations related to vaginal side effects. Results: Fifty-seven radiation oncologists responded to the survey. The most used dose fraction schemes for adjuvant VBT were 7 Gy x 3 fractions (30%), 5.5 Gy x 5 fractions (26%), and 6 Gy x 5 fractions (28%). The preferred VBT scheme was 5 Gy x 3 fractions (50%) when the external beam radiotherapy (EBRT) dose was 45 Gy external radiotherapy, while the preferred schemes were 6 Gy x 3 fractions (30%) or 5 Gy x 3 fractions (32%) when the external radiotherapy dose was increased to 50.4 Gy. One-half of the respondents delivered VBT twice a week, and the dose was prescribed to 0.5 cm from vaginal mucosa by 86% of the respondents. There was no common definition for the dose prescription length, which was defined as 3 cm from the vaginal cuff in 33% of responses and as 4 cm in 35% of responses. For serous and clear cell histological types, 38% of the respondents targeted "full cylinder length". To prevent vaginal side effects, 78% of the respondents recommended using a vaginal dilator and/or sexual intercourse after VBT. Conclusions: This survey revealed variations in the clinical practice of VBT among Turkish radiation oncologists, which suggests that standardization is necessary.
引用
收藏
页码:152 / 157
页数:6
相关论文
共 50 条
  • [31] The role for vaginal cuff brachytherapy boost after external beam radiation therapy in endometrial cancer
    Griffith, Timothy
    Nwachukwu, Chika
    Albuquerque, Kevin
    Gaffney, David
    BRACHYTHERAPY, 2022, 21 (02) : 177 - 185
  • [32] Adjuvant vaginal cuff brachytherapy in surgically treated endometrial carcinoma patients - in view of the recent evidence
    Serkies, Krystyna
    Baczkowska-Waliszewska, Zuzanna
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2021, 13 (02) : 221 - 230
  • [33] Influence of Robotic Hysterectomy on Delayed Vaginal Cuff Healing and Brachytherapy Initiation in Endometrial Carcinoma Patients
    Stahl, J. M.
    Park, H. S. M.
    Damast, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E256 - E256
  • [34] Preliminary Results of the American Brachytherapy Society Survey of Practice Patterns for Vaginal Brachytherapy for Postoperative Endometrial Cancer
    Harkenrider, M. M.
    Erickson, B. A.
    Viswanathan, A. N.
    Grover, S.
    Small, W. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S110 - S110
  • [35] THE ROLE OF VAGINAL BRACHYTHERAPY IN THE TREATMENT OF ENDOMETRIAL CANCER
    Akis, Serkan
    Ozturk, Ugur Kemal
    Keles, Esra
    Api, Murat
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A157 - A158
  • [36] The Comparison of Vaginal Cuff Brachytherapy and External Pelvic Radiotherapy in Stage IB Grade 3 Endometrial Cancer
    Esen, S. Beduk
    Kahvecioglu, A.
    Yigit, E.
    Yedekci, F. Y.
    Gursel, O. Kandemir
    Sari, S. Yuce
    Yildirim, B. Akkus
    Gultekin, M.
    Yildiz, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E675 - E676
  • [37] Predictive Factors for Recurrence Following Postoperative Vaginal Cuff Brachytherapy Alone for Stage I Endometrial Cancer
    Dunn, E. F.
    Gondi, V.
    Bradley, K. A.
    Platta, C. S.
    Anderson, B. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S97 - S97
  • [38] Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancer
    Dunn, Emily F.
    Geye, Heather
    Platta, Chris S.
    Gondi, Vinai
    Rose, Stephen
    Bradley, Kristin A.
    Anderson, Bethany M.
    GYNECOLOGIC ONCOLOGY, 2014, 133 (03) : 494 - 498
  • [39] Electronic brachytherapy for postsurgical adjuvant vaginal cuff irradiation therapy in endometrial and cervical cancer: A retrospective study
    Kamrava, Mitchell
    Chung, Melody P.
    DeMarco, John
    Kayode, Oluwatosin
    Park, Sang-June
    Borja, Lalaine
    Chow, Lucy
    Lee, Steve P.
    Steinberg, Michael L.
    Demanes, D. Jeffrey
    BRACHYTHERAPY, 2013, 12 (02) : 141 - 147
  • [40] A Phase 3 Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High-Risk, Early-Stage Endometrial Cancer: A Gynecology Oncology Group Study
    Randall, M.
    Filiaci, V.
    McMeekin, D.
    Yashar, C. M.
    Mannel, R.
    Salani, R.
    DiSilvestro, P.
    Burke, J.
    Rutherford, T.
    Spirtos, N.
    Cho, J.
    Kim, J.
    Anderson, P.
    Brewster, W.
    Small, W.
    Carney, M.
    Aghajanian, C.
    Miller, D. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (05): : 1313 - 1313